Novo's new insulin pen allows finer-scale adjustments

08/21/2013 | Drug Store News

Novo Nordisk received federal approval for its NovoPen Echo insulin pen, which enables half-unit dosing. The smaller doses allow for more precise adjustments, particularly helpful for treating children with diabetes. The device, the first of its kind in the U.S., also features a memory function that keeps track of dose and time frame between shots.

View Full Article in:

Drug Store News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC